Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.24B |
| 2 |
Microsoft
MSFT
|
+$433M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$419M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$332M |
| 5 |
RTX Corp
RTX
|
+$322M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AABA
Altaba Inc
AABA
|
+$267M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$181M |
| 3 |
BCR
CR Bard Inc.
BCR
|
+$134M |
| 4 |
IQVIA
IQV
|
+$134M |
| 5 |
LVLT
Level 3 Communications Inc
LVLT
|
+$121M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.07% |
| 2 | Financials | 5.97% |
| 3 | Healthcare | 5.8% |
| 4 | Consumer Discretionary | 5.2% |
| 5 | Communication Services | 4.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RGC
5051
PUT
DELISTED
Regal Entertainment Group
RGC
| $115K | ﹤0.01% |
5,000
+700
| +16% | +$12.9K |
|
|
AKTX
5052
Akari Therapeutics
AKTX
$13M
| $114K | ﹤0.01% |
+33
| New | +$127K |
|
5053
ICL Group
ICL
$6.72B
| $114K | ﹤0.01% |
28,363
-5,246
| -16% | -$21.8K |
|
5054
Metallus
MTUS
$906M
| $114K | ﹤0.01% |
7,492
-5,996
| -44% | -$91.2K |
|
|
FFG
5055
DELISTED
FBL Financial Group
FFG
| $114K | ﹤0.01% |
1,636
+1,406
| +611% | +$105K |
|
|
JMBA
5056
DELISTED
Jamba, Inc.
JMBA
| $114K | ﹤0.01% |
14,246
| – | – |
|
5057
Camden National
CAC
$1.01B
| $113K | ﹤0.01% |
2,690
+2,069
| +333% | +$90K |
|
5058
Lattice Semiconductor
LSCC
$18.3B
| $113K | ﹤0.01% |
19,547
-28,486
| -59% | -$167K |
|
|
CARO
5059
DELISTED
Carolina Financial Corp.
CARO
| $113K | ﹤0.01% |
3,026
+2,679
| +772% | +$99.1K |
|
5060
Aclaris Therapeutics
ACRS
$858M
| $112K | ﹤0.01% |
4,532
-2,925
| -39% | -$71.2K |
|
5061
Amphastar Pharmaceuticals
AMPH
$885M
| $112K | ﹤0.01% |
5,784
+4,942
| +587% | +$92.3K |
|
5062
CALL
First Horizon
FHN
$12.4B
| $112K | ﹤0.01% |
5,600
+5,100
| +1,020% | +$98.2K |
|
5063
CALL
Groupon
GRPN
$1.07B
| $112K | ﹤0.01% |
1,100
-2,015
| -65% | -$212K |
|
5064
PUT
Ingredion
INGR
$6.51B
| $112K | ﹤0.01% |
800
+300
| +60% | +$39.6K |
|
|
PRO
5065
DELISTED
PROS Holdings
PRO
| $112K | ﹤0.01% |
4,231
-8,078
| -66% | -$203K |
|
5066
CALL
Papa John's
PZZA
$998M
| $112K | ﹤0.01% |
2,000
-3,100
| -61% | -$193K |
|
|
CNXM
5067
DELISTED
CNX Midstream Partners LP
CNXM
| $112K | ﹤0.01% |
+6,705
| New | +$112K |
|
5068
DB Gold Double Long ETN due February 15, 2038
DGP
$237M
| $111K | ﹤0.01% |
4,447
| – | – |
|
|
GOOD
5069
Gladstone Commercial Corp
GOOD
$592M
| $111K | ﹤0.01% |
5,291
+208
| +4% | +$4.61K |
|
|
GREK
5070
CALL
Global X MSCI Greece ETF
GREK
$318M
| $111K | ﹤0.01% |
3,600
-5,333
| -60% | -$150K |
|
5071
Manchester United
MANU
$3.88B
| $111K | ﹤0.01% |
5,600
-164
| -3% | -$3.16K |
|
5072
Global X MLP ETF
MLPA
$2.26B
| $111K | ﹤0.01% |
+1,868
| New | +$109K |
|
5073
Titan International
TWI
$474M
| $111K | ﹤0.01% |
8,623
+5,964
| +224% | +$66.3K |
|
|
WSR
5074
DELISTED
Whitestone REIT
WSR
| $111K | ﹤0.01% |
7,728
+4,152
| +116% | +$58.7K |
|
|
VNTR
5075
DELISTED
Venator Materials PLC
VNTR
| $111K | ﹤0.01% |
4,995
-9,605
| -66% | -$221K |
|
Similar funds
Barclays's Q4 2017 Portfolio in Review
As of Q4 2017, Barclays held 7,416 positions worth $122B, up 26% from $97.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays deployed $19.9B of net new capital in Q4 2017, opening 435 new positions and adding to 3,853 existing holdings. Its largest new stake was iShares US Home Construction ETF: 198,606 shares worth $8.68M.
By sector, the portfolio is most concentrated in Technology at 7.1% of assets, up from 6.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Altaba Inc, an estimated $267M trimmed.
- Barclays's largest Q4 2017 buy was iShares US Home Construction ETF: 198,606 shares worth $8.68M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.24B increase.
- Barclays's biggest Q4 2017 reduction was Altaba Inc, cutting an estimated $267M.
- Barclays fully exited CR Bard Inc. in Q4 2017, selling an estimated $134M.
- Barclays's ten largest holdings make up 24% of its $122B portfolio in Q4 2017.
- Barclays opened 435 new positions and closed 356 in Q4 2017.
- Barclays's portfolio value rose 26% quarter-over-quarter to $122B.
Based on Barclays's 13F filing for Q4 2017, filed 14 Feb 2018.